Buchter V, Ong Y.C, Mouvet F, Ladaycia A, Lepeltier E, Rothlisberger U, Keiser J, Gasser G. Multidisciplinary preclinical investigations on three oxamniquine analogues as novel drug candidates for schistosomiasis. Chemistry. 2020(in press). DOI: 10.1002/chem.202002856

2020
Journal Article
PubMed (32852116)

Buchter V, Priotti J, Leonardi D, Lamas M.C, Keiser J. Activity of novel oral formulations of albendazole and mebendazole against Heligmosomoides polygyrus in vitro and in vivo. J Pharm Sci. 2020;109(5):1819-1826. DOI: 10.1016/j.xphs.2020.02.002

2020
Journal Article
PubMed (32070702)

Buchter V, Priotti J, Leonardi D, Lamas M.C, Keiser J. Preparation, physicochemical characterization and In vitro and In vivo activity against Heligmosomoides polygyrus of novel oral formulations of albendazole and mebendazole. J Pharm Sci. 2020;109(5):1819-1826. DOI: 10.1016/j.xphs.2020.02.002

2020
Journal Article
PubMed (32070702)

Buchter V, Hess J, Gasser G, Keiser J. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy. Parasit Vectors. 2018;11(1):580. DOI: 10.1186/s13071-018-3132-x

2018
Journal Article
PubMed (30400935)
Link